Everbliss 5mg - Everolimus Tablets

Everbliss 5mg - Everolimus Tablets About

Evermil 10mg tablet is an antineoplastic drug belonging to the class of mTOR kinase inhibitors, containing the active ingredient everolimus. It is used to treat advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and also in the treatment of subependymal giant cell astrocytoma (tumours are found in the ventricles of the brain). Good oral hygiene and regular dental check-ups are important during the treatment since this medicine can cause sores or ulcers in the mouth. It is often combined with cyclophosphamide, an alkylating agent, to treat subependymal giant cell astrocytoma.
Before taking this medicine, it is necessary to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, Evermil 10mg tablet increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of the skin, joint pain, or swelling during this treatment. You must limit your exposure to sunlight and UV light by wearing protective clothing and applying sunscreen frequently, as this medicine may increase the risk of developing cancers. Avoid taking grapefruit juice or grapefruit while taking this medicine.
This tablet is not recommended for adolescents and children under the age of 18. Contact your doctor immediately if you experience shortness of breath, chest pain, or worsening cough. During the Evermil 10mg tablet treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. This medicine has the potential to cause kidney problems. Report to your doctor if you have been diagnosed with liver disorders, heart failure, high blood cholesterol levels, or hypertension before starting this treatment. Avoid live vaccines and close contact with those who have received live vaccines.

Mechanism of Action

Everbliss 5mg contains everolimus, which acts as an mTOR inhibitor. This mechanism targets and disrupts the growth pathways within certain cancer cells, slowing down their development and potentially enhancing treatment outcomes for conditions like breast cancer and renal cell carcinoma.


Storage and Handling

Proper storage is essential for maintaining Everbliss 5mg's effectiveness. Keep the tablets below 30C in a cool, dry location, away from direct light and moisture to prevent degradation and preserve potency throughout their 24-month shelf life.


Therapeutic Uses

Everbliss 5mg is indicated for patients diagnosed with specific types of cancer such as breast cancer, renal cell carcinoma, neuroendocrine tumors, and tumors linked to tuberous sclerosis complex. The tablets provide a targeted approach for managing these complex diseases when used as directed by a healthcare professional.